This toolkit consists of a collection of evidence-based resources related to Subcutaneous Depot Medroxyprogesterone Acetate, or DMPA-SC. It is available below as an interactive toolkit hosted on our website. You may also download a pdf or word doc version. This toolkit was originally released 10/21/2021 and was updated on 10/12/2023.
This protocol template is written with several decision points that must be addressed before the protocol is ready for use. Local agencies can use this protocol template to tailor content to their own organization. Decision points are identified as ‘NOTE‘ in the template protocol. Local agencies should only include information that reflects their own organization’s current practices.
This job aid provides concise information for providers about depomedroxyprogesterone acetate (DMPA) as a home or self-administered option.
This depomedroxyprogesterone acetate administration calendar can be used by providers, health care organizations and/or patients to track date ranges to ensure effectiveness of the method.
This job aid provides language for presenting self-administration of subcutaneous depomedroxyprogesterone acetate (DMPA SC) as an option for those who desire DMPA and less trips to the clinical setting.
This new resource, Coding and Billing Recommendations for Counseling, Education and Ongoing Monitoring of Patients Electing to use DMPA Subcutaneously (SubQ) via Self-administration, will help family planning providers document activities related to provision of self-administered SubQ DMPA, including ICD-10 Diagnosis Codes and Procedure Codes. Modifiers for telehealth visits are included.
